Company intelligence / Profile preview

Patrys Limited

Melbourne, Victoria, Australiapatrys.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Patrys has developed a pipeline of natural human antibody therapies for oncology and inflammatory disease. Its lead programs have demonstrated safety and some efficacy signals in early-phase trials. For example, PAT-SC1 showed a ten-year survival benefit in treated gastric cancer patients. PAT-SM6 completed a Phase I/IIa trial in relapsed/refractory multiple myeloma with no significant adverse events and evidence of stable disease in some patients at day +36 post-treatment. The company continues to advance its pipeline through internal development and partnerships.

Therapeutic areas: OncologyImmunology
Modalities: Natural human antibodies (including deoxymabs)Monoclonal antibodies (mAbs)
Industry: Biotech

Drug pipeline

9 assets

PAT-SM6

8 more assets in the full pipeline.

Request access →

Partnerships

Onyx Pharmaceuticals / Amgen Inc. sponsoring combination trial for PAT-SM6 in multiple myeloma

Beyond the preview

Go deeper on Patrys Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Patrys Limited.

Explore the full profile